In year 6, KFF Health News-NPR’s ‘Bill of the Month’ helps patients in a changing system

In 2023, our nationwide reporting team has been hard at work on a holiday gift to you: a packet of advice for navigating the labyrinthine American medical system.

McKinsey hit with a $650M fine for deceiving US about opioid consulting work

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 14, 2024

The surprising role of RNA in immune interactions

In a groundbreaking exploration of cell surface biology, Ryan Flynn has uncovered a surprising role for RNA outside the confines of the cell. Flynn’s research,

August 22, 2024

Anti-VEGF Ocular Implant for Age-Related Macular Degeneration to Return to Market

The ranibizumab ocular implant (Susvimo) for neovascular (wet) age-related macular degeneration (nAMD) will return to the U.S. market “in the coming weeks,” Genentech announced. The

July 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.